AU3595393A - Transdermal administration of buprenorphine in the form of ion pair complexes - Google Patents
Transdermal administration of buprenorphine in the form of ion pair complexesInfo
- Publication number
- AU3595393A AU3595393A AU35953/93A AU3595393A AU3595393A AU 3595393 A AU3595393 A AU 3595393A AU 35953/93 A AU35953/93 A AU 35953/93A AU 3595393 A AU3595393 A AU 3595393A AU 3595393 A AU3595393 A AU 3595393A
- Authority
- AU
- Australia
- Prior art keywords
- buprenorphine
- transdermal administration
- ion pair
- pair complexes
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82795092A | 1992-01-31 | 1992-01-31 | |
US827950 | 1992-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3595393A true AU3595393A (en) | 1993-09-01 |
Family
ID=25250560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35953/93A Abandoned AU3595393A (en) | 1992-01-31 | 1993-01-27 | Transdermal administration of buprenorphine in the form of ion pair complexes |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3595393A (en) |
WO (1) | WO1993014727A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814084B4 (en) | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation |
DE10019171A1 (en) * | 2000-04-07 | 2001-10-18 | Schering Ag | Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients |
US8246980B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
DE10234673B4 (en) | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS |
DE10261696A1 (en) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Device for the transdermal administration of rotigotine base |
CN110441302B (en) * | 2018-05-03 | 2021-12-07 | 中国医学科学院药物研究所 | Nondestructive quality control method for tulobuterol transdermal patch |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
-
1993
- 1993-01-27 WO PCT/US1993/000733 patent/WO1993014727A1/en active Application Filing
- 1993-01-27 AU AU35953/93A patent/AU3595393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993014727A1 (en) | 1993-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU627845B2 (en) | Improvements in or relating to devices for administration of drugs or the like | |
EP0535111A4 (en) | Transdermal administration of buprenorphine | |
AU3401895A (en) | Spiro-azabicyclic compounds useful in therapy | |
AU5784994A (en) | Formulation for use in smokers | |
AU4338289A (en) | Cyclodextrin-peptide complexes | |
AU7237394A (en) | Morphinan derivative and medicinal use | |
AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
AU3290089A (en) | Deprenyl for systemic transdermal administration | |
AU665287B2 (en) | Prostaglandin combinations in glaucoma therapy | |
AU3152993A (en) | Improvements in the administration of aerosol compounds | |
AU1907788A (en) | N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy | |
AU622779B2 (en) | Keggin ion compounds in HIV treatment | |
AU1111388A (en) | Triazinetriones as agents against protozoa in insects | |
AU3552189A (en) | Use of metal chelate complexes in dehalogenation | |
AU3595393A (en) | Transdermal administration of buprenorphine in the form of ion pair complexes | |
AU574926B2 (en) | Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates | |
AU4860693A (en) | Piperidine derivatives, their preparation and their application in therapy | |
AU1870292A (en) | Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity | |
AU7793791A (en) | Pharmaceutical composition for use in treating pain | |
AU4060289A (en) | Therapeutic agents | |
AU4980693A (en) | Improvements in skin plasters | |
AU4579793A (en) | Improvements in and relating to biscuits | |
AU627033B2 (en) | 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives, their preparation and their application in therapy | |
AU2192783A (en) | 3:,5:-diarabinosides preparation and application in therapy | |
AU6491890A (en) | Use of arylalkylamides in the treatment of neurodegenerative diseases |